The BD insulin syringe with the BD Ultra-Fine™ needle features their shortest insulin syringe needle, at 53% shorter than the 12.7-mm needle. This length is supported by the latest recommendations published in Mayo Clinic Proceedings that advocate using the shortest needle first-line for all patient categories. In fact, in a 2010 study, 80% of patients preferred shorter needles compared to 8-mm and 12.7-mm needles. They also deliver insulin into the subcutaneous tissue, reducing the risk of painful intramuscular (IM) injection.

• The insulin syringe comes in four different barrel sizes and scale capacities to optimize dose
• Longer needle lengths may lead to frequent IM vs subcutaneous tissue injections, which may cause unexplained hypoglycemia